Marilyn Davis

627 total citations
24 papers, 505 citations indexed

About

Marilyn Davis is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Marilyn Davis has authored 24 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Marilyn Davis's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (7 papers) and HER2/EGFR in Cancer Research (6 papers). Marilyn Davis is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (7 papers) and HER2/EGFR in Cancer Research (6 papers). Marilyn Davis collaborates with scholars based in United States. Marilyn Davis's co-authors include Ossama Tawfik, Sanjoy Das, Bruce F. Kimler, Sudhansu K. Dey, Jian Tan, Fang Fan, Kareem O. Tawfik, Meiling Li, Yi Tan and Bibhash C. Paria and has published in prestigious journals such as Developmental Biology, International Journal of Radiation Oncology*Biology*Physics and Transplantation.

In The Last Decade

Marilyn Davis

23 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilyn Davis United States 12 200 150 141 133 125 24 505
Virginie Dangles‐Marie France 9 196 1.0× 150 1.0× 121 0.9× 293 2.2× 47 0.4× 17 666
Jingly F. Weier United States 12 90 0.5× 65 0.4× 101 0.7× 312 2.3× 36 0.3× 36 675
Marlijn van Zutphen Netherlands 8 540 2.7× 43 0.3× 101 0.7× 122 0.9× 37 0.3× 8 622
Melissa S. DeRycke United States 10 129 0.6× 66 0.4× 79 0.6× 163 1.2× 43 0.3× 14 439
Michael J. White United States 11 65 0.3× 86 0.6× 226 1.6× 253 1.9× 40 0.3× 21 599
Gulnar A. Surveyor United States 9 374 1.9× 28 0.2× 28 0.2× 320 2.4× 177 1.4× 9 668
Prabodh Kapoor United States 8 35 0.2× 66 0.4× 200 1.4× 583 4.4× 60 0.5× 9 709
Saeed Reza Ghaffari Iran 12 78 0.4× 40 0.3× 64 0.5× 405 3.0× 33 0.3× 33 694
Scott D. Brown Canada 11 447 2.2× 152 1.0× 524 3.7× 280 2.1× 21 0.2× 15 822
Norman G. Nagl United States 7 88 0.4× 85 0.6× 133 0.9× 696 5.2× 77 0.6× 7 744

Countries citing papers authored by Marilyn Davis

Since Specialization
Citations

This map shows the geographic impact of Marilyn Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn Davis more than expected).

Fields of papers citing papers by Marilyn Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn Davis. The network helps show where Marilyn Davis may publish in the future.

Co-authorship network of co-authors of Marilyn Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn Davis. A scholar is included among the top collaborators of Marilyn Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn Davis. Marilyn Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tawfik, Ossama, et al.. (2015). Whole-Slide Imaging of Pap Cellblock Preparations Is a Potentially Valid Screening Method. Acta Cytologica. 59(2). 187–200. 12 indexed citations
3.
Rao, Deepthi, Bruce F. Kimler, Warren B. Nothnick, et al.. (2015). Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non–triple-negative breast cancers. Human Pathology. 46(6). 876–883. 16 indexed citations
4.
5.
Tawfik, Kareem O., Bruce F. Kimler, Marilyn Davis, Fang Fan, & Ossama Tawfik. (2012). Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant. Human Pathology. 44(1). 39–46. 34 indexed citations
6.
Davis, Marilyn, Bruce F. Kimler, Fang Fan, et al.. (2011). Grading ductal carcinoma in situ of the breast using an automated proliferation index.. PubMed. 41(2). 122–30. 4 indexed citations
7.
Tawfik, Kareem O., Bruce F. Kimler, Marilyn Davis, Fang Fan, & Ossama Tawfik. (2011). Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between “triple-negative” and non–“triple-negative” tumors. Human Pathology. 43(1). 23–30. 44 indexed citations
8.
Tawfik, Ossama, Bruce F. Kimler, Marilyn Davis, et al.. (2010). Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.. PubMed. 40(4). 315–23. 15 indexed citations
9.
Tawfik, Ossama, Bruce F. Kimler, Marilyn Davis, et al.. (2007). Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 450(6). 627–636. 20 indexed citations
10.
Dhillon, Navneet K., David M. Pinson, Ossama Tawfik, et al.. (2007). Bleomycin treatment causes enhancement of virus replication in the lungs of SHIV-infected macaques. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(5). L1233–L1240. 5 indexed citations
11.
Tomita, Tatsuo, et al.. (2005). Phyllodes tumor of borderline malignancy: Seven year follow up with immunohistochemical study. Pathology International. 55(9). 585–589. 2 indexed citations
12.
Gao, Xin, et al.. (2005). Prognostic Significance of Ploidy, MIB-1 Proliferation Marker, and p53 in Renal Cell Carcinoma. Journal of the American College of Surgeons. 201(4). 565–570. 19 indexed citations
13.
Tan, Yi, Meiling Li, Marilyn Davis, et al.. (2003). HB-EGF directs stromal cell polyploidy and decidualization via cyclin D3 during implantation. Developmental Biology. 265(1). 181–195. 95 indexed citations
14.
Davis, Marilyn. (2003). eVote adds elections to mailing lists. Linux journal. 2003(107). 1. 1 indexed citations
15.
Tomita, Tatsuo, et al.. (2003). Phyllodes Tumor of Borderline Malignancy: A 7-Year Follow-Up. The Breast Journal. 9(4). 333–334. 1 indexed citations
16.
17.
Connor, Carol S., et al.. (2002). A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens. The American Journal of Surgery. 184(4). 322–324. 53 indexed citations
18.
Teh, Bin S., Gustavo E. Ayala, W. Mai, et al.. (2002). Phase I/II trial evaluating combined radiotherapy and in-situ gene therapy with or without hormonal therapy in the treatment of prostate cancer-an interim report on PSA response and biopsy data. International Journal of Radiation Oncology*Biology*Physics. 54(2). 138–138. 2 indexed citations
19.
Przepiorka, Donna, Cindy Ippoliti, Ka‐Wah Chan, et al.. (1994). INTERLEUKIN-2 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATION. Transplantation. 58(7). 858–860. 8 indexed citations
20.
Davis, Marilyn. (1993). Renal cell carcinoma. Seminars in Oncology Nursing. 9(4). 267–271. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginie Dangles‐Marie Breakdown of academic impact, for papers by Jingly F. Weier Breakdown of academic impact, for papers by Marlijn van Zutphen Breakdown of academic impact, for papers by Melissa S. DeRycke Breakdown of academic impact, for papers by Michael J. White Breakdown of academic impact, for papers by Gulnar A. Surveyor Breakdown of academic impact, for papers by Prabodh Kapoor Breakdown of academic impact, for papers by Saeed Reza Ghaffari Breakdown of academic impact, for papers by Scott D. Brown Breakdown of academic impact, for papers by Norman G. Nagl
Rankless by CCL
2026